Photocure supports this new EAU UROwebinar for healthcare professionals in #urology: Nightmare Cases in Bladder Cancer! Nov 5: episode 3 of the series "Everything You Always Wanted to Know about TURBT but Were Afraid to Ask" webinars.uroweb.org/EAU/webinars/1…

Photocure today reported Hexvix®/Cysview® revenues of NOK 120.1 million in the third quarter of 2024, up 12% year over year, and generated NOK 5.0 million in EBITDA for the period. The Company reiterated its 2024 financial guidance. Read more: photocure.com/news/photocure…

Join us at the French Urology Congress on 20-23 November! Stop by at Booth B03 to connect with our team and learn more about how we can support your practice. We look forward to seeing you there. #FrenchUrologyCongress #CFU2024 #Urology #bladdercancer

Meet the team at the Photocure booth at the 25th Annual Meeting of the Society of Urologic Oncology December: 4-6, 2024 in Dallas, TX! suonet.org/meetings/upcom… #bladdercancer #SUO2024 #Urology #Oncology

Thank you for all your support in 2024, rich in events: photocure.com/news. Happy New Year! We look forward to a healthy & successful 2025 with you.

Photocure proudly supports the UROwebinar series: "Everything you always wanted to know about TURBT but were afraid to ask". 1st Episode “How to approach TURBT in MIBC” on February 25, 2025, 18:30 - 19:30 CET Healthcare Professionals Reg: UROwebinar: webinars.uroweb.org/login

Photocure today reported Hexvix®/Cysview® revenues of NOK 128.6 million in the the fourth quarter of 2024 (Q4 2023: NOK 114.2 million) and EBITDA of NOK 8.5 million (NOK 29.9 million). Read more: photocure.com/news/photocure…

Photocure is attending the EAU Congress in Madrid, 21-24 March 2025! Visit us at Booth B28 to learn more about how we’re leading change in bladder cancer. See you there! #EAU25 #BladderCancer #LeadingChange #SeeingIsBelieving

Photocure is attending the EAU Congress in Madrid starting today! Come meet our team at Booth B28. #EAU25 #BladderCancer #LeadingChange #SeeingIsBelieving

Photocure's Annual Report and integrated ESG report for 2024 has been published today: cms.photocure.com/uploads/202426…

Photocure is a proud sponsor of the Bladder Cancer Advocacy Network's (#BCAN) Walk to End Bladder Cancer. This year, Photocure team members are walking in 12 of the 19 Walks throughout the U.S. #Bladdercancer #bladdercancerawarenessmonth #bladdercanceraware2025

Do we need TURBT in MIBC? For healthcare professionals: join Episode 2 of the UROwebinar series on TURBT, focusing on the role of TURBT in MIBC. Register for the webinar 6 May at 18:30 CEST uroweb.org/education-even… #UROwebinar #BladderCancer #TURBT #MIBC #Urology #Medicaleducation

Photocure today reported Hexvix®/Cysview® revenues of NOK 125.3 million in Q1 2025 (Q1 2024: NOK 116.8 million), and an EBITDA of NOK 1.8 million (7.9). Read more: photocure.com/news/photocure…

Bladder Cancer Roadshow again! May is #BladderCancerAwarenessMonth and the tour bus from Photocure and our partners this year, MSD Germany and Olympus Germany, will stop at many hospitals and congresses in Germany and Austria starting tomorrow in Gladbeck! blasenkrebsroadshow.de

#BladderCancerAwarenessMonth of May: Photocure is once again supporting the Swedish Bladder Cancer Patient organization and their bladder cancer seminar on May 22, 6-8pm CET in Malmö, also being broadcast live: blascancerforbundet.se #bladdercancer #aware #medicaleducation

Many symptoms of #bladdercancer could at first appear to be something else entirely. Do you have blood in your urine? Be sure it’s not bladder cancer and get checked. #BladderCancerMonth25 #GetChecked World Bladder Cancer Patient Coalition

A resounding success! “Strong together –​ united against bladder cancer​” is the motto of Photocure’s 3rd Bladder Cancer roadshow that continues through June 26, training healthcare professional teams in #bladdercancer management aspects. #awareness #medicaltraining

Photocure is a proud sponsor of BCAN's Walk to End Bladder Cancer. This year, our teams in the U.S. walked in 9 of 19 local walks and raised 100% of our donations goal. Congratulations to BCAN for another successful Walk event! Bladder Cancer Advocacy Network #bladdercancer #BladderCancerAware

Photocure starts up commercial operations in Spain 🇪🇸 Exciting news: with the launch of our sales, marketing, and direct distribution operations, we aim to bring innovative solutions to the Spanish market & its unique needs. #bladdercancer #expansion photocure.com/news/photocure…

Photocure today reported Hexvix®/Cysview® revenues of NOK 135.6 million in Q2 2025 (Q2 2024: NOK 122.4 million), and an EBITDA of NOK 14.8 million (27.8 incl. milestones). Read more: photocure.com/news/photocure…